Increase in P-glycoprotein accompanied by activation of protein kinase Cα and NF-κB p65 in the livers of rats with streptozotocin-induced diabetes

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 5, 2008, Pages 355-360

  Kameyama, Natsumi ^a   Arisawa, Sakiko ^a   Ueyama, Jun ^a   Kagota, Satomi ^b   Shinozuka, Kazumasa ^b   Hattori, Ai ^c   Tatsumi, Yasuaki ^c   Hayashi, Hisao ^c   Takagi, Kenji ^a   Wakusawa, Shinya ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Diabetes; I B; Liver; Mdr1b; NF B p65; PKC ; Rat; Streptozotocin

Indexed keywords

ANTIBODY; BREAST CANCER RESISTANCE PROTEIN; BSEP PROTEIN; C219 ANTIBODY; GLYCOPROTEIN P; I KAPPA B; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MDR1A PROTEIN; MDR1B PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; OAT2 PROTEIN; OAT3 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN KINASE C ALPHA; STREPTOZOCIN; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HYPERGLYCEMIA; LIVER; MALE; MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; LIVER; MALE; ORGAN SIZE; P-GLYCOPROTEIN; PHENOTYPE; PROTEIN KINASE C-ALPHA; PROTEIN TRANSPORT; RATS; RATS, WISTAR; STREPTOZOCIN; TRANSCRIPTION FACTOR RELA;

RATTUS;

EID: 42749094567     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.02.005     Document Type: Article

References (46)

1. Lothstein L., Hsu S.I., Horwitz S.B., and Greenberger L.M. Alternate overexpression of two P-glycoprotein genes is associated with changes in multidrug resistance in a J774.2 cell line. J. Biol. Chem. 264 (1989) 16054-16058
2. Nakatsukasa H., Silverman J.A., Gant T.W., Evarts R.P., and Thorgeirsson S.S. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology 18 (1993) 1202-1207
3. Ziemann C., Burkle A., Kahl G.F., and Hirsch-Ernst K.I. Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures. Carcinogenesis 20 (1999) 407-414
4. Hinoshita E., Taguchi K., Inokuchi A., Uchiumi T., Kinukawa N., Shimada M., Tsuneyoshi M., Sugimachi K., and Kuwano M. Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J. Hepatol. 35 (2001) 765-773
5. Fouassier L., Beaussier M., Schiffer E., Rey C., Barbu V., Mergey M., Wendum D., Callard P., Scoazec J.Y., Lasnier E., Stieger B., Lienhart A., and Housset C. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. Am. J. Physiol. Gastrointest. Liver Physiol. 293 (2007) G25-G35
6. van Waarde W.M., Verkade H.J., Wolters H., Havinga R., Baller J., Bloks V., Muller M., Sauer P.J., and Kuipers F. Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats. Gastroenterology 122 (2002) 1842-1852
7. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40 (1997) S3-S8
8. Chaudhary P.M., and Roninson I.B. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol. Res. 4 (1992) 281-290
9. Osborn M.T., Berry A., Ruberu M.S., Ning B., Bell L.M., and Chambers T.C. Phorbol ester induced MDR1 expression in K562 cells occurs independently of mitogen-activated protein kinase signaling pathways. Oncogene 18 (1999) 5756-5764
10. Brady J.M., Cherrington N.J., Hartley D.P., Buist S.C., Li N., and Klaassen C.D. Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab. Dispos. 30 (2002) 838-844
11. Vos T.A., Hooiveld G.J., Koning H., Childs S., Meijer D.K., Moshage H., Jansen P.L., and Muller M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28 (1998) 1637-1644
12. Mercier C., Decleves X., Masseguin C., Fragner P., Tardy M., Roux F., Gabrion J., and Scherrmann J.M. P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes. J. Neurochem. 87 (2003) 820-830
13. Cooper M.E., Bonnet F., Oldfield M., and Jandeleit-Dahm K. Mechanisms of diabetic vasculopathy: an overview. Am. J. Hypertens. 14 (2001) 475-486
14. Koya D., and King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes 47 (1998) 859-866
15. Pieper G.M., and Riaz-ul-Haq. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J. Cardiovasc. Pharmacol. 30 (1997) 528-532
16. Bierhaus A., Schiekofer S., Schwaninger M., Andrassy M., Humpert P.M., Chen J., Hong M., Luther T., Henle T., Kloting I., Morcos M., Hofmann M., Tritschler H., Weigle B., Kasper M., Smith M., Perry G., Schmidt A.M., Stern D.M., Haring H.U., Schleicher E., and Nawroth P.P. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50 (2001) 2792-2808
17. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J., 9 (1995) 484-496
18. Ohno S., and Nishizuka Y. Protein kinase C isotype and their specific functions: prologue. J. Biochem. 132 (2002) 509-511
19. Banzi M., Aguiari G., Trimi V., Mangolini A., Pinton P., Witzgall R., Rizzuto R., and del Senno L. Polycystin-1 promotes PKCalpha-mediated NF-kappaB activation in kidney cells. Biochem. Biophys. Res. Commun. 350 (2006) 257-262
20. Kiemer A.K., Vollmar A.M., Bilzer M., Gerwig T., and Gerbes A.L. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J. Hepatol. 33 (2000) 236-246
21. Craven P.A., and DeRubertis F.R. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J. Clin. Invest. 83 (1989) 1667-1675
22. Tang E.Y., Parker P.J., Beattie J., and Houslay M.D. Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. FEBS Lett. 326 (1993) 117-123
23. Croquet F., Bréhier A., Gil S., Davy J., and Féger J. Five isoenzymes of protein kinase C are expressed in normal and STZ-diabetic rat hepatocytes: effect of phorbol 12-myristate 13-acetate. Biochim. Biophys. Acta 1315 (1996) 163-168
24. Nivet V., Antoine P.J., Amessou M., Descamps G., Desbuquois B., Clot J.P., and Durand D. Increased expression of liver PKC alpha in hypoinsulinemic diabetic rats: a post-translational effect. Mol. Cell. Endocrinol. 146 (1998) 177-185
25. Cornwell M.M. The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription. Cell Growth Differ. 1 (1990) 607-615
26. Bentires-Alj M., Barbu V., Fillet M., Chariot A., Relic B., Jacobs N., Gielen J., Merville M.P., and Bours V. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22 (2003) 90-97
27. Lin S.B., Wu L.C., Huang S.L., Hsu H.L., Hsieh S.H., Chi C.W., and Au L.C. In vitro and in vivo suppression of growth of rat liver epithelial tumor cells by antisense oligonucleotide against protein kinase C-alpha. J. Hepatol. 33 (2000) 601-608
28. Tramonti G., Xie P., Wallner E.I., Danesh F.R., and Kanwar Y.S. Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes. Am. J. Physiol. Renal Physiol. 291 (2006) F972-F980
29. Liu H., Xu X., Yang Z., Deng Y., Liu X., and Xie L. Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats. Brain Res. 1123 (2006) 245-252
30. Yu G., Ahmad S., Aquino A., Fairchild C.R., Trepel J.B., Ohno S., Suzuki K., Tsuruo T., Cowan K.H., and Glazer R.I. Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun. 3 (1991) 181-189
31. Ahmad S., and Glazer R.I. Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Mol. Pharmacol. 43 (1993) 858-862
32. Kang N., Alexander G., Park J.K., Maasch C., Buchwalow I., Luft F.C., and Haller H. Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Intern. 56 (1999) 1737-1750
33. Suzuki S., Hayashi H., Takagi K., Kondo T., Takagi K., Ueyama J., and Wakusawa S. Protein kinase Cbeta isoform down-regulates the expression of MDR3 P-glycoprotein in human Chang liver cells. Biochim. Biophys. Acta 1760 (2006) 1552-1557
34. Huang L., Zhao A., Lew J.L., Zhang T., Hrywna Y., Thompson J.R., de Pedro N., Royo I., Blevins R.A., Pelaez F., Wright S.D., and Cui J. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J. Biol. Chem. 278 (2003) 51085-51090
35. Liu Y., Binz J., Numerick M.J., Dennis S., Luo G., Desai B., MacKenzie K.I., Mansfield T.A., Kliewer S.A., Goodwin B., and Jones S.A. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J. Clin. Invest. 112 (2003) 1678-1687
36. Nishikawa T., Edelstein D., and Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Inter., Suppl. 77 (2000) S26-S30
37. Pinton P., Rimessi A., Marchi S., Orsini F., Migliaccio E., Giorgio M., Contursi C., Minucci S., Mantovani F., Wieckowski M.R., Del Sal G., Pelicci P.G., and Rizzuto R. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 315 (2007) 659-663
38. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., and Baeuerle P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365 (1993) 182-185
39. Thevenod F., Friedmann J.M., Katsen A.D., and Hauser I.A. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J. Biol. Chem. 275 (2000) 1887-1896
40. Silverman J.A., Raunio H., Gant T.W., and Thorgeirsson S.S. Cloning and characterization of a member of the rat multidrug resistance (mdr) gene family. Gene 106 (1991) 229-236
41. Brown K., Park S., Kanno T., Franzoso G., and Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2532-2536
42. Sun S.C., Ganchi P.A., Ballard D.W., and Greene W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259 (1993) 1912-1915
43. Kim H.J., Kim K.W., Yu B.P., and Chung H.Y. The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic. Biol. Med. 28 (2000) 683-692
44. Kim H.J., Yu B.P., and Chung H.Y. Molecular exploration of age-related NF-kappaB/IKK downregulation by calorie restriction in rat kidney. Free Radic. Biol. Med. 32 (2002) 991-1005
45. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., and Ghosh S. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80 (1995) 573-582
46. Suyang H., Phillips R., Douglas I., and Ghosh S. Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B. Mol. Cell. Biol. 16 (1996) 5444-5449